Ionis Pharmaceuticals
IONS
IONS
350 hedge funds and large institutions have $6.3B invested in Ionis Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 131 increasing their positions, 107 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 354 → 350 (-4)
8% less capital invested
Capital invested by funds: $6.83B → $6.3B (-$526M)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
350
Holding in Top 10
3
Calls
$38M
Puts
$24.8M
Top Buyers
| 1 | +$223M | |
| 2 | +$86.8M | |
| 3 | +$70M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$61.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$48.5M |
Top Sellers
| 1 | -$69.5M | |
| 2 | -$51.3M | |
| 3 | -$44.8M | |
| 4 |
ClearBridge Investments
New York
|
-$18.3M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$15.5M |